JCIA
VIR icon

Jackson Creek Investment Advisors’s Vir Biotechnology VIR Stock Holding History

Jackson Creek Investment Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21,070
Closed -$542K – 381
2022
Q1 		$542K Buy
21,070
+994
+5% +$29.5K 0.2% 230
2021
Q4 		$841K Buy
+20,076
New +$787K 0.3% 188

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Jackson Creek Investment Advisors's VIR Position: Q2 2022 in Review

Jackson Creek Investment Advisors sold out of Vir Biotechnology (VIR) in Q2 2022, closing a stake of 21,070 shares — an estimated $542K sold.

Jackson Creek Investment Advisors first reported a position in VIR in Q4 2021 and held it in 2 quarters. The position peaked at $841K in Q4 2021. 211 funds tracked by Wall St. Rank hold VIR as of Q2 2022.

  • Jackson Creek Investment Advisors reported no remaining Vir Biotechnology position as of Q2 2022 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 21,070 Vir Biotechnology shares in Q2 2022, an estimated $542K.
  • Jackson Creek Investment Advisors first reported a position in Vir Biotechnology in Q4 2021 and held it in 2 quarters.
  • Jackson Creek Investment Advisors's Vir Biotechnology position peaked at $841K in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2022.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2022, filed 4 Aug 2022.